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A truncated form of cytochrome P450IID6 deprived of 22 NH,-terminal amino acids residues (P450IID6dl-22) was found in both the cytosol and 
the microsomal fraction of the yeast, Saccharomyces cerevisiue. A reduced CO difference spectrum of this form was characterized by the absence 
of absorption at 448 nm and weak absorption at 420 nm. Another peculiarity of P450IID6dl-22 expression was its reduced content in the yeast 
cells compared to that of P450IID6, with the intracellular levels of the corresponding mRNAs being the same. We suggest hat the deleted form 
of P450IID6, i.e. lacking 22 NH*-terminal ammo acid residues, is not inserted properly in the endoplasmic reticulum membrane: it does not take 
up the proper ~nfo~ation to enable normal heme binding and is degraded in the yeast cells. 
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1. INTRODUCTION 
Cytochrome P450IID6, like other members of the 
cytochrome P450 family, is an integral part of the endo- 
plasmic reticulum. According to the latest findings, 
these proteins seem to be cytoplasmic with a short NH2- 
terminus spanning the membrane [l]. Most probably, 
the latter fulfils two functions [2-4]. First, it plays the 
part of an uncleavable signal sequence by providing a 
means for signal recognition particle-mediated insertion 
of the growing polypeptide chain into the membrane. 
Second, it serves as a stoptransfer signal which arrests 
co-translational translocation of the polypeptide chain 
through the membrane such that it is predominantly 
exposed to the cytoplasm. 
To verify this suggestion cDNAs for truncated forms 
of P45Os lacking 22-30 amino-terminal amino acid res- 
idues were constructed and expressed in bacterial and 
yeast cells [5-81. These truncated P45Os exhibited cata- 
lytic activity independent of whether they were mem- 
brane bound [5,6] or soluble [8]. 
Thus the functions of the amino-terminal amino acid 
residues in cytochrome P450 topogenesis are still ob- 
scure. In this work we have made an effort to clarify the 
role of the amino-terminus of human cytochrome 
The nucleotide sequence ncoding cytochrome P45OIID6 was pre- 
pared from a plasmid con~~ing the CYP2D6 gene with a modified 
5’ region by the PCR method [9]. These procedures will be described 
in detail elsewhere. The truncated version of the CYPZD6 gene lacking 
the codons for 22 NH,-terminal ammo acids (CYP2D6dl-66) was 
constructed by the PCR method, too. To this end the initial nucleotide 
sequence was cloned in the pGEM4 plasmid and used as a template 
for amplification. The PCR copy was prepared using the CGGATC- 
CATGCACCGGCGC primer with twelve 3’-terminal nucleotides 
identical to the 67-79 region of the CYP2D6 gene and seven 5’- 
terminal nucleotides designed to form a Bun&II restriction site in the 
PCR copy, as well as the standard GTCGACTCTAGAG primer that 
is part of the pGEM4 polylinker region. Taking into account he large 
size of tlte DNA fragment under copying, the amplification (30 cycles: 
94”C, 0.5 min; 55”C, 2 min, 75”C, 3 min) was carried out with Pfu 
DNA polymerase (Strata~ne, USA) with a high 3’-5’ endonuclease 
activity and a low level of errors during DNA replication. The PCR 
product was cleaved by BarnHI and EcQRI endonucleases, cloned in 
pGEM4 and sequenced according to [lo]. The clones bearing the 
CYP2D6.41-66 gene free of side mutations were selected. The 
CYP2D6 and CYP2D6dld6 genes were re-cloned into the pYeDPl/ 
8-2 shuttle vector under the control of the inducible GALlO-CYCI 
promoter [l l] at the BamHI//ZcoRI restriction sites as described [12]. 
The resulting constructions were used to transform Saccharomyces 
cerevisiue strain 2805 (a MAT pep4::His3 prb 1-S can1 Gal2 his36 
ura3-52) by electroporation [13]. The conditions for promoter induc- 
tion were given in [l 11. 
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P450IID6 in its insertion into the endoplasmic reticu- 
lum membrane of the yeast, Saccharomyces cerevisiae. 
2. MATERIALS AND METHODS 
Published by Elsevier Science Publishers 13. K 87 
Volume 336, number 1 FEBS LETTERS December 1993 
cording to [15] using monoclonal anti-P450IID6 antibodies. The con- 
tent of P450IID6 in the microsomal fraction was evaluated from 
reduced CO difference spectra recorded with a Hitachi 557 spectro- 
photometer automatically correcting the base-line. The extinction co- 
efficient for cytochrome P450 was taken equal to 91 mM_’ . cd. The 
protein concentration in the microsomal fractions was measured in the 
presence of 1% sodium cholate by the method of Lowry [16]. 
Oxidation of debrisoquine by the microsomal fractions was per- 
formed in a reaction mixture containing 2.4 mM debrisoquine, 4.8 
mM NADPH and 0.56 PM microsomal P450IID6 in 0.1 M potassium 
phosphate buffer (pH 7.4) at 37°C. The reaction products were ex- 
tracted with methylene chloride and analyzed by high pressure liquid 
chromatography using a Supelco Cl8 5~ column (250 x 4.6 mm) and 
a Varian Star-9000 high pressure chromatograph supplied with a 
fluorescent detector (a, = 220 nm; &,,, > 300 nm). 
3. RESULTS AND DISCUSSION 
3.1. Synthesis of mRNAs for cytochromes P45OIID6 and 
P45OIZD6Al-22 in Saccharomyces cerevisiae 
Total RNA was isolated from the transformed yeast 
cells growing for 24-36 h and analyzed by the Northern 
hybridization method using 32P-labeled cDNA for 
P450IID6 as a probe. Fig. 1 shows that mRNA, hybrid- 
ized with the specific probe, was accumulated in the 
yeast strains bearing plasmids YeDP (CYP2D6) and 
YeDP(CYP2D6Al-66). The length of mRNA, synthe- 
sized in these strains, was about 2,000 bp. Thus, cDNAs 
encoding both full-size P450IID6 and its shortened 
form, lacking the NH,-terminal membrane insertion 
signal, were transcribed in the yeast cells. Judging from 
the intensities of the bands in the autoradiographs, as 
well as from radioactivities of the corresponding zones 
of the gels, evaluated by liquid scintillation counting, 
the transcription of both cDNAs was maintained at 
nearly the same level. 
3.2. Characterization of P45OIID6 synthesized in yeast 
cells 
To characterize P450IID6 synthesized in yeast cells 
microsomal and post-microsomal fractions were iso- 
lated and subjected to SDS-electrophoresis n 10% poly- 
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Fig. 1. Northern blot analysis of P450IID6 and P450IID6dl-22 
mRNAs. The total nucleic acid fraction (10 pg) prepared from 
2805(pYeDP) (lane l), 2805(pYeDP/CYP2D6) (lane 2) and 
2805(pYeDP/CYP2D6dl-66) (lane 3) were analyzed by 1% agarose 
gel electrophoresis, transferred to nitrocellulose filters, and then hy- 
bridized. The arrows indicate the positions of the yeast 18 S and 28 S 
RNA bands used as markers. 
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Fig. 2. Western blot analysis of P450IID6 and P450IID6dl-22 in the 
transformed yeast cells. Lanes: 1,60 pg of post-microsomal supema- 
tant protein from 2805(pYeDP/CYP2D6,4-66); 2, 15 pug of micro- 
somal protein from 2805@YeDP/CYP2D5dl-66); 3, 15 pg of micro- 
somal protein from 2805(pYeDP/CYP2D6); 4, 30 pug of microsomal 
protein from human hepatocytes. 
acrylamide gels followed by immunoblotting with mon- 
oclonal antibodies against P450IID6. As is seen from 
Fig. 2, the microsomal fraction of yeast transformed 
with the plasmid containing the cDNA for P450IID6 
contains a protein reacting to the anti- P450IID6 anti- 
bodies. The mobility of this protein during SDS-PAGE 
was identical to that of P450IID6 detected by the same 
method in human liver microsomes (Fig. 2), and corre- 
sponded to a molecular mass of 57 kDa in line with 
literature data [ 171. 
Fig. 3 shows the CO difference spectrum of the micro- 
somal fraction with a pronounced peak at 448 nm spe- 
cific for all native cytochrome P45Os. Absorbance at this 
wave length corresponded to 160 pmol of P450IID6 per 
mg of microsomal protein, i.e. 0.9% of the total micro- 
somal protein. 
As could be expected on the basis of the spectral data, 
P450IID6, incorporated into the yeast microsomal 
membranes, was able to catalyze oxidative hydroxyla- 
tion of its specific substrate, namely debrisoquine. Fig. 
4 represents the results of analysis of the reaction mix- 
tures by HPLC. Comparing chromatographic patterns 
for the cases when the mixture contained (dotted lines) 
and did not contain (solid lines) P450IID6 in the yeast 
microsomes, it can be seen that the arrow-marked peak 
corresponds to the product of debrisoquine conversion. 
A similar pattern was observed when human liver mi- 
crosomes were substituted for microsomes from yeast 
transformed with YeDP(CYP2D6) (not shown). 
Thus, the cDNA for P450IID6 when expressed in 
yeast cells, gives the intact protein localized mainly in 
the endoplasmic reticulum membrane and capable of 
transforming specific substrates by coupling with en- 
dogenous NADPH:cytochrome P450 reductase. 
3.3. Characterization of P45OIIDAl-22 synthesized in 
yeast cells 
In this case fractionation of the transformed cells 
followed by SDS-PAGE and immunoblotting demon- 
strated a protein reacting to the anti-P450IID6 antibod- 
ies and characterized by molecular weight as close to 
that of P450IID6 (Fig. 2). Two specific details should 
be mentioned: (1) the total intracellular content of 
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Fig. 3. Fe*’ vs. Fe” CO difference spectra of microsomes and total 
cell homogenate. The differential absorption spectra (sodium di- 
thionite reduced carbon monoxide) of a yeast microsome suspension 
(in 100 mM KH*PO,, pH 7.4) and total cell homogenate were re- 
corded: 1, microsomes from 2805(pYeDP/2CYP2D6); 2, microsomes 
from 2805~YeDP/CY~~~l~6); 3, total cell homogenate from 
2805~YeDP/CY~D6dl~). 
P45OIID_41-22 was approximately one order of magni- 
tude lower than that of P450IID6, (ii) the intracellular 
localization of P450IIDUl-22 was dual, i.e. both mi- 
crosomal and cytosolic, since an essential fraction of the 
protein was detected in the post-microsomal superna- 
tant. As mentioned above, the content of mRNAs for 
P450IID6 and P450IID6dl-22 were similar if not iden- 
tical. Therefore the reduced content of P450IID6dl-22 
is likely to have resulted from its enhanced degradation 
which in turn was due to aberrant insertion into the 
endoplasmic reticulum membrane. 
In contrast to P45OIID6, P450IID6dl-22 synthesized 
in the yeast cells did not show any absorbance at 450 
m, either in the microsomal or cytosolic fractions (Fig. 
3). A very weak peak at 420 nm was observed. 
The above data suggest hat either P450IID6dl-22 
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Fig. 4. HPLC analysis of the products of debrisoquine oxidation by 
the isolated microsomes. 1, extract of the reaction mixture after the 
reaction with microsomes from 28OS(pYeDP); 2, extract of the reac- 
tion mixture after the reaction with microsomes from 28OS~YeDP/ 
CYP2D6). 
cannot normally bind the heme residue or this protein 
is completely denatured during the procedure of subcel- 
lular fractionation. The former statement seems to be 
more reasonable, especially in the light of the data of 
Clark and Waterman [18] who have shown that a short- 
ened form of cytochrome P45017a, lacking 17 NH2- 
terminal amino acid residues, cannot be expressed in a 
catalytically active and heme-containing form in COS-1 
cells. 
By and large, the data on the role of the ~~-te~nal 
membrane insertion signal in the incorporation of the 
cytochrome P450 polypeptide chain into membranes 
and in its ability to accept the heme-containing form are 
rather controversial. 
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